BIG
DGX icon

Brooklyn Investment Group’s Quest Diagnostics DGX Stock Holding History

Brooklyn Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$736K Buy
3,754
+1,193
+47% +$232K 0.02% 742
2025
Q4 		$449K Buy
2,561
+917
+56% +$167K 0.02% 743
2025
Q3 		$292K Sell
1,644
-29
-2% -$5.15K 0.04% 439
2025
Q2 		$300K Buy
1,673
+113
+7% +$19.6K 0.04% 445
2025
Q1 		$264K Buy
1,560
+245
+19% +$40.2K 0.06% 285
2024
Q4 		$198K Buy
1,315
+68
+5% +$10.6K 0.06% 247
2024
Q3 		$194K Buy
+1,247
New +$186K 0.06% 247

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Brooklyn Investment Group's DGX Position: Q1 2026 in Review

Brooklyn Investment Group increased its Quest Diagnostics (DGX) stake by 47% in Q1 2026, buying an estimated $232K and bringing the position to 3,754 shares worth $736K. The position accounts for 0.02% of the portfolio, ranked #742.

Brooklyn Investment Group first reported a position in DGX in Q3 2024 and has held it in 7 quarters since. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Brooklyn Investment Group held 3,754 shares of Quest Diagnostics worth $736K as of Q1 2026.
  • Brooklyn Investment Group bought 1,193 Quest Diagnostics shares in Q1 2026, an estimated $232K.
  • Quest Diagnostics made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #742 holding.
  • Brooklyn Investment Group first reported a position in Quest Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.